SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-19-002100
Filing Date
2019-11-01
Accepted
2019-11-01 16:12:18
Documents
1
Group Members
ROBERTO MIGNONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT bridger-atra102219.htm SC 13G 72595
  Complete submission text file 0001172661-19-002100.txt   74246
Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Filed by) CIK: 0001166309 (see all company filings)

IRS No.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 191186968
SIC: 2836 Biological Products, (No Diagnostic Substances)